Asia-Pacific
Takeda’s Phase IIb TAK-279 trial meets primary and secondary endpoints
The trial evaluated the tolerability, efficacy, and safety of TAK-279 in moderate-to-severe plaque psoriasis patients.
Study shows mixed relationship between alcohol consumption and dementia
AstraZeneca and Daiichi Sankyo report positive data from trial of Enhertu
Asia Pacific dominates Phase I clinical trials: a trend analysis
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Incannex begins Phase II trial of combination drug for rheumatoid arthritis
Japan’s PMDA grants clearance for Priothera to commence AML therapy trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
